955,643 Maximus, Inc. $MMS Shares Sold by Van Berkom & Associates Inc.

Key Points

• Van Berkom & Associates cut its Maximus stake by 87.8%, selling 955,643 shares in the third quarter and retaining 132,403 shares worth about $7.0 million.
• Other institutional investors added or initiated positions, and institutions collectively own 97.21% of Maximus shares. An insider also sold 3,208 shares.
• Maximus declared a quarterly dividend of $0.33 per share, equivalent to a 2.0% yield; analyst coverage cited in the article gives the stock a consensus Hold rating.

Van Berkom & Associates Inc. reduced its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 87.8% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 132,403 shares of the health services provider's stock after selling 955,643 shares during the period. Van Berkom & Associates Inc. owned approximately 0.25% of Maximus worth $7,043,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of MMS. BlackRock Inc. acquired a new position in shares of Maximus in the 2nd quarter valued at about $400,186,000. Reinhart Partners LLC. grew its holdings in Maximus by 131.8% during the second quarter. Reinhart Partners LLC. now owns 1,982,415 shares of the health services provider's stock worth $106,575,000 after acquiring an additional 1,127,346 shares during the period. Bank of America Corp DE purchased a new position in Maximus during the second quarter valued at approximately $31,487,000. Bank of New York Mellon Corp purchased a new position in Maximus during the second quarter valued at approximately $26,239,000. Finally, Walleye Capital LLC purchased a new position in Maximus during the second quarter valued at approximately $20,645,000. Hedge funds and other institutional investors own 97.21% of the company's stock.

Insider Transactions at Maximus

In other Maximus news, insider Michelle Link sold 3,208 shares of the stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $54.23, for a total transaction of $173,969.84. Following the transaction, the insider directly owned 13,881 shares of the company's stock, valued at $752,766.63. This trade represents a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.80% of the stock is currently owned by insiders.

Maximus Trading Down 0.2%

Shares of MMS stock opened at $65.39 on Tuesday. Maximus, Inc. has a 1-year low of $51.04 and a 1-year high of $100.00. The company has a market cap of $3.42 billion, a price-to-earnings ratio of 9.66 and a beta of 0.57. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.42 and a quick ratio of 2.42. The stock has a 50 day simple moving average of $58.87 and a 200-day simple moving average of $64.22.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 30th. Shareholders of record on Friday, November 13th will be issued a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a yield of 2.0%. The ex-dividend date of this dividend is Friday, November 13th. Maximus's dividend payout ratio (DPR) is presently 19.50%.

Analyst Upgrades and Downgrades

MMS has been the subject of a number of analyst reports. Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a report on Saturday, August 8th. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a research report on Monday, August 17th. Finally, Zacks Research raised shares of Maximus from a "strong sell" rating to a "hold" rating in a research note on Thursday, October 1st. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat, Maximus presently has a consensus rating of "Hold".

Maximus Profile

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.